This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Standigm Inc, Ajou University Industry-Academic Cooperation Foundation, Sk Chemicals. Active years: 2025-2026.
Company Filing History:
3 out of 3 
1 out of 382 
1 out of 11 Years Active: 2025-2026
Title: Hee Jung Koo: Innovator in Synucleinopathy Treatment
Introduction
Hee Jung Koo is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. With a total of 3 patents, her work focuses on innovative solutions for complex neurological disorders.
Latest Patents
One of her latest patents is a composition for treating synucleinopathies. This composition includes efavirenz or a salt or solvate thereof, along with a pharmaceutically acceptable carrier. It is designed to prevent or treat conditions such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. The composition works by hindering cell-to-cell transmission of alpha-synuclein, preventing intracellular aggregation of α-synuclein, and inhibiting the transmission of aggregated α-synuclein. Another notable patent is a method for identifying associations between disease-related factors from document data. This invention allows for the recognition of disease-related factors included in document data and the extraction of relations between these factors.
Career Highlights
Hee Jung Koo has worked with notable companies in her field, including Standigm Inc and SK Holdings Co., Ltd. Her experience in these organizations has contributed to her expertise and innovative approach to research and development.
Collaborations
Throughout her career, Koo has collaborated with esteemed colleagues such as Tae Yong Kim and Young Sang Paik. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Hee Jung Koo's contributions to the field of synucleinopathy treatment highlight her innovative spirit and dedication to medical research. Her patents reflect a commitment to improving the lives of those affected by neurological disorders.